8-K Announcements
6Material company update
May 7, 2026·SEC
Material company update
May 7, 2026·SEC
Material company update
Feb 25, 2026·SEC
Alector, Inc.(ALEC)Earnings, Financials & Key Ratios
ALEC•NASDAQ
Price updated Jun 19, 2026
AboutAlector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis diseases; and AL101 that is in Phase I clinical trial for the treatment of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. The company also offers AL002, a product candidate that is in Phase II clinical trial for the treatment of Alzheimer's disease; and AL003, which is in Phase I clinical trial for the treatment of Alzheimer's disease. In addition, its products in development stage include AL044 that targets MS4A4A, a risk gene for Alzheimer's disease. Alector, Inc. has a collaboration agreement with Adimab, LLC for the research and development of antibodies; and a strategic collaboration agreement with GlaxoSmithKline plc for the development and commercialization of monoclonal antibodies, such as AL001 and AL101 to treat neurodegenerative diseases. The company was founded in 2013 and is headquartered in South San Francisco, California.Show more
- Revenue$21M-79.1%
- EBITDA-$136M
- Net Income-$143M-20.1%
- EPS (Diluted)-1.39-13.0%
- Gross Margin54.09%-45.9%
- EBITDA Margin-646.93%-377.8%
- Operating Margin-692.83%-380.5%
- Net Margin-679.16%-473.7%
- ROE-181.56%-99.0%
ALEC Key Insights
Alector, Inc. (ALEC) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓High quality earnings: Operating CF exceeds net income
✗Weaknesses
- ✗Weak Piotroski F-Score: 1/9
- ✗Negative free cash flow
- ✗Trading more than 30% below 52-week high
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when ALEC posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
ALEC Price & Volume
Alector, Inc. (ALEC) stock price & volume — 10-year historical chart
Loading chart...
ALEC Growth Metrics
Alector, Inc. (ALEC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-0.05%
3 Years-46%
TTM-79.15%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-1.58%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM6.38%
Return on Capital
10 Years-30.34%
5 Years-28.38%
3 Years-38.32%
Last Year-51.43%
ALEC Recent Earnings
Alector, Inc. (ALEC) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 12/12 qtrs (100%)●Beat Revenue 8/12 qtrs (67%)
Q2 2026Latest
May 7, 2026Metric
Actual
Est
EPS
$0.21+40.0%
$0.35
Rev
$1M-89.2%
$10M
Q1 2026
Feb 25, 2026Metric
Actual
Est
EPS
$0.34+12.8%
$0.39
Rev
$6M+218.6%
$2M
Q4 2025
Nov 6, 2025Metric
Actual
Est
EPS
$0.34+19.0%
$0.42
Rev
$3M+82.8%
$2M
Q3 2025
Aug 7, 2025Metric
Actual
Est
EPS
$0.30+33.3%
$0.45
Rev
$8M+180.7%
$3M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 7, 2026 | $0.21vs $0.35+40.0% | $1Mvs $10M-89.2% |
| Q1 2026 | Feb 25, 2026 | $0.34vs $0.39+12.8% | $6Mvs $2M+218.6% |
| Q4 2025 | Nov 6, 2025 | $0.34vs $0.42+19.0% | $3Mvs $2M+82.8% |
| Q3 2025 | Aug 7, 2025 | $0.30vs $0.45+33.3% | $8Mvs $3M+180.7% |
Based on last 12 quarters of dataView full earnings history →
ALEC Peer Comparison
Alector, Inc. (ALEC) competitors in Neuroscience and Psychiatry Therapies — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 PRTA | 467.51M | 8.93 | -1.97 | -92.84% | -260.92% | -49.88% | 0.05 | |
 ACAD | 3.7B | 21.62 | 9.44 | 11.87% | 34.3% | 35.65% | 0.04 | |
 SAVA | 63.77M | 1.32 | -2.54 | -95.77% | ||||
 AVXL | 252.99M | 2.73 | -5.06 | -38.76% | ||||
 INMB | 38.55M | 1.45 | -0.78 | 257.14% | -170.86% | 0.04 | ||
 BIIB | 29.02B | 196.58 | 22.26 | 1.39% | 13.92% | 7.55% | 0.38 | |
 IONS | 12.25B | 74.12 | -31.14 | 33.87% | -30.87% | -58.57% | 5.35 | |
 ARVN | 494.88M | 7.67 | -5.99 | -0.3% | -247.54% | -44.39% | 0.02 |
Compare ALEC vs Peers
Alector, Inc. (ALEC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
ALEC Income Statement
Alector, Inc. (ALEC) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 3.73M | 27.68M | 21.22M | 21.1M | 207.09M | 133.62M | 97.06M | 100.56M | 21.05M | 18.42M |
Revenue Growth % | 797.84% | 641.02% | -23.33% | -0.57% | 881.54% | -35.48% | -27.36% | 3.6% | -79.07% | -79.15% |
Cost of Goods Sold | 29.91M | 73.03M | 100.53M | 156.87M | 189.41M | 0 | 8.85M | 0 | 9.66M | 2.08M |
COGS % of Revenue | 800.83% | 263.87% | 473.76% | 743.53% | 91.46% | - | 9.12% | - | 45.91% | - |
Gross Profit | -26.18M▲ 0% | -45.35M▼ 73.3% | -79.31M▼ 74.9% | -135.77M▼ 71.2% | 17.68M▲ 113.0% | 133.62M▲ 655.8% | 88.21M▼ 34.0% | 100.56M▲ 14.0% | 11.38M▼ 88.7% | 16.33M▲ 0% |
Gross Margin % | -700.83% | -163.87% | -373.76% | -643.53% | 8.54% | 100% | 90.88% | 100% | 54.09% | 88.68% |
Gross Profit Growth % | -97.44% | -73.27% | -74.87% | -71.19% | 113.02% | 655.84% | -33.98% | 13.99% | -88.68% | - |
Operating Expenses | 36.41M | 84.97M | 35.09M | 59.4M | 55.04M | 271.45M | 239.95M | 245.56M | 157.19M | 152.86M |
OpEx % of Revenue | 974.94% | 306.99% | 165.39% | 281.56% | 26.58% | 203.16% | 247.22% | 244.19% | 746.93% | - |
Selling, General & Admin | 6.5M | 11.93M | 33.94M | 59.4M | 55.04M | 61.03M | 56.69M | 59.62M | 53.99M | 47.37M |
SG&A % of Revenue | 174.11% | 43.12% | 159.94% | 281.56% | 26.58% | 45.68% | 58.4% | 59.28% | 256.53% | - |
Research & Development | 29.91M | 73.03M | 100.53M | 156.87M | 189.41M | 210.42M | 192.12M | 185.94M | 123.06M | 108.58M |
R&D % of Revenue | 800.83% | 263.87% | 473.76% | 743.53% | 91.46% | 157.48% | 197.93% | 184.91% | 584.77% | - |
Other Operating Expenses | 199K | 5.04M | -99.37M | -156.87M | -189.41M | 0 | -8.85M | 0 | -19.86M | -2M |
Operating Income | -32.68M▲ 0% | -57.29M▼ 75.3% | -114.4M▼ 99.7% | -195.17M▼ 70.6% | -37.36M▲ 80.9% | -137.83M▼ 268.9% | -151.74M▼ 10.1% | -145M▲ 4.4% | -145.81M▼ 0.6% | -136.53M▲ 0% |
Operating Margin % | -874.94% | -206.99% | -539.16% | -925.08% | -18.04% | -103.16% | -156.33% | -144.19% | -692.83% | -741.33% |
Operating Income Growth % | -115.96% | -75.31% | -99.7% | -70.6% | 80.86% | -268.93% | -10.09% | 4.44% | -0.56% | - |
EBITDA | -32M | -56.27M | -110.63M | -187.91M | -29.05M | -129.36M | -142.89M | -136.16M | -136.15M | -127.73M |
EBITDA Margin % | -856.73% | -203.31% | -521.37% | -890.65% | -14.03% | -96.82% | -147.22% | -135.4% | -646.93% | -693.54% |
EBITDA Growth % | -114.31% | -75.85% | -96.61% | -69.86% | 84.54% | -345.38% | -10.46% | 4.71% | 0.01% | 7.16% |
D&A (Non-Cash Add-back) | 680K | 1.02M | 3.77M | 7.26M | 8.31M | 8.47M | 8.85M | 8.84M | 9.66M | 8.8M |
EBIT | -32.68M | -57.29M | -113.25M | -195.17M | -37.36M | -137.83M | -151.74M | -145M | -142.76M | -133.59M |
Net Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Income/Expense | 199K | 5.04M | 9.02M | 4.95M | 1.03M | 7.78M | 26.56M | 26.08M | 3.05M | 11.31M |
Pretax Income | -32.48M▲ 0% | -52.25M▼ 60.9% | -105.39M▼ 101.7% | -190.23M▼ 80.5% | -36.33M▲ 80.9% | -130.06M▼ 258.0% | -125.18M▲ 3.7% | -118.92M▲ 5.0% | -142.76M▼ 20.0% | -125.22M▲ 0% |
Pretax Margin % | -869.61% | -188.78% | -496.65% | -901.64% | -17.54% | -97.33% | -128.97% | -118.26% | -678.36% | -679.92% |
Income Tax | 0 | 0 | 0 | 0 | 0 | 3.25M | 5.21M | 128K | 168K | 168K |
Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | -2.5% | -4.16% | -0.11% | -0.12% | -0.13% |
Net Income | -32.48M▲ 0% | -52.25M▼ 60.9% | -105.39M▼ 101.7% | -190.23M▼ 80.5% | -36.33M▲ 80.9% | -133.31M▼ 267.0% | -130.39M▲ 2.2% | -119.05M▲ 8.7% | -142.93M▼ 20.1% | -125.39M▲ 0% |
Net Margin % | -869.61% | -188.78% | -496.65% | -901.64% | -17.54% | -99.77% | -134.34% | -118.39% | -679.16% | -680.83% |
Net Income Growth % | -114.96% | -60.86% | -101.7% | -80.51% | 80.9% | -266.95% | 2.19% | 8.7% | -20.06% | -1.58% |
Net Income (Continuing) | -32.48M | -52.25M | -105.39M | -190.23M | -36.33M | -133.31M | -130.39M | -119.05M | -142.93M | -125.39M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -0.63▲ 0% | -0.76▼ 20.6% | -1.62▼ 113.2% | -2.45▼ 51.2% | -0.45▲ 81.6% | -1.62▼ 260.0% | -1.56▲ 3.7% | -1.23▲ 21.2% | -1.39▼ 13.0% | -1.13▲ 0% |
EPS Growth % | 64.61% | -20.63% | -113.16% | -51.23% | 81.63% | -260% | 3.7% | 21.15% | -13.01% | 6.38% |
EPS (Basic) | -0.63 | -0.76 | -1.62 | -2.45 | -0.45 | -1.62 | -1.56 | -1.23 | -1.39 | - |
Diluted Shares Outstanding | 51.22M | 68.37M | 61.73M | 77.76M | 80.42M | 82.47M | 83.73M | 96.59M | 103M | 110.59M |
Basic Shares Outstanding | 51.22M | 68.37M | 61.73M | 77.76M | 80.42M | 82.47M | 83.73M | 96.59M | 103M | 110.59M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
ALEC Balance Sheet
Alector, Inc. (ALEC) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 232.97M | 293.18M | 357.44M | 421.51M | 749.71M | 726.43M | 565.81M | 424.82M | 266.45M | 215.08M |
Cash & Short-Term Investments | 32.45M | 290.41M | 353.07M | 413.31M | 735.25M | 712.85M | 548.86M | 413.4M | 256.02M | 206.51M |
Cash Only | 32.45M | 65.47M | 89.64M | 49.97M | 329.15M | 154.32M | 74.56M | 33.02M | 65.8M | 76.96M |
Short-Term Investments | 0 | 224.94M | 263.43M | 363.34M | 406.1M | 558.53M | 474.31M | 380.38M | 190.22M | 129.55M |
Accounts Receivable | 200.24M | 0 | 0 | 0 | 7.39M | 2.59M | 0 | 0 | 0 | 0 |
Days Sales Outstanding | 19.57K | - | - | - | 13.03 | 7.07 | - | - | - | - |
Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - |
Other Current Assets | 0 | 2.77M | 0 | 0 | 0 | 0 | 16.95M | 11.42M | 10.43M | 8.57M |
Total Non-Current Assets | 3.09M | 15.18M | 64.48M | 66.74M | 64.94M | 61.21M | 56.02M | 43.49M | 26.79M | 24.83M |
Property, Plant & Equipment | 2.83M | 10.94M | 62.33M | 62.65M | 57.9M | 53.33M | 47.06M | 37.1M | 24.55M | 22.62M |
Fixed Asset Turnover | 1.32x | 2.53x | 0.34x | 0.34x | 3.58x | 2.51x | 2.06x | 2.71x | 0.86x | 0.69x |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long-Term Investments | 0 | 1.47M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.85M |
Other Non-Current Assets | 252K | 2.77M | 2.15M | 4.09M | 7.05M | 7.88M | 8.96M | 6.39M | 2.23M | 2.21M |
Total Assets | 236.06M▲ 0% | 308.36M▲ 30.6% | 421.91M▲ 36.8% | 488.25M▲ 15.7% | 814.66M▲ 66.9% | 787.65M▼ 3.3% | 621.83M▼ 21.1% | 468.3M▼ 24.7% | 293.24M▼ 37.4% | 239.92M▲ 0% |
Asset Turnover | 0.02x | 0.09x | 0.05x | 0.04x | 0.25x | 0.17x | 0.16x | 0.21x | 0.07x | 0.06x |
Asset Growth % | 336.25% | 30.63% | 36.83% | 15.72% | 66.85% | -3.32% | -21.05% | -24.69% | -37.38% | -151.2% |
Total Current Liabilities | 27.4M | 13.04M | 61.97M | 68.09M | 139.56M | 93.81M | 177.95M | 125.06M | 69.5M | 40.97M |
Accounts Payable | 1.14M | 126K | 278K | 3M | 4.75M | 4.19M | 3.77M | 2.21M | 1.69M | 1.42M |
Days Payables Outstanding | 13.91 | 0.63 | 1.01 | 6.99 | 9.15 | - | 155.73 | - | 63.89 | 441.71 |
Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.42M | 10.62M |
Deferred Revenue (Current) | 18.98M | 34.91M | 30.16M | 23.89M | 90.8M | 48.23M | 82.97M | 23.66M | 6.68M | 26.81M |
Other Current Liabilities | 5.6M | 9.56M | 5.73M | 7.29M | 11.66M | 12.76M | 54.74M | 54.55M | 51.71M | 22.2M |
Current Ratio | 8.50x | 22.48x | 5.77x | 6.19x | 5.37x | 7.74x | 3.18x | 3.40x | 3.83x | 5.25x |
Quick Ratio | 8.50x | 22.48x | 5.77x | 6.19x | 5.37x | 7.74x | 3.18x | 3.40x | 3.83x | 5.25x |
Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - |
Total Non-Current Liabilities | 260.69M | 392.71M | 165.2M | 152.63M | 374.38M | 479.4M | 309.72M | 216.44M | 193.09M | 188.57M |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.39M | 26.81M | 23.93M |
Capital Lease Obligations | 0 | 0 | 41.47M | 43.74M | 39.81M | 35.27M | 30.46M | 24.38M | 0 | 40.33M |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 77.54M | 7.57M | 493K | 472K | 158K | 759K | 68.42M | 10.51M | 166.27M | 1.77M |
Total Liabilities | 288.09M | 405.76M | 227.17M | 220.72M | 513.93M | 573.21M | 487.67M | 341.5M | 262.59M | 229.53M |
Total Debt | 0 | 0 | 48.04M | 51.26M | 47.6M | 43.33M | 38.92M | 42.52M | 36.23M | 34.55M |
Net Debt | -32.45M | -65.47M | -41.6M | 1.29M | -281.55M | -111M | -35.64M | 9.5M | -29.57M | -42.41M |
Debt / Equity | - | - | 0.25x | 0.19x | 0.16x | 0.20x | 0.29x | 0.34x | 1.18x | 3.33x |
Debt / EBITDA | - | - | - | - | - | - | - | - | - | -0.27x |
Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | 0.33x |
Interest Coverage | - | - | - | - | - | - | - | - | - | - |
Total Equity | -52.03M▲ 0% | -97.4M▼ 87.2% | 194.74M▲ 299.9% | 267.53M▲ 37.4% | 300.72M▲ 12.4% | 214.44M▼ 28.7% | 134.16M▼ 37.4% | 126.8M▼ 5.5% | 30.65M▼ 75.8% | 10.38M▲ 0% |
Equity Growth % | -108.91% | -87.19% | 299.95% | 37.38% | 12.41% | -28.69% | -37.44% | -5.48% | -75.83% | -269.06% |
Book Value per Share | -1.02 | -1.42 | 3.15 | 3.44 | 3.74 | 2.60 | 1.60 | 1.31 | 0.30 | 0.09 |
Total Shareholders' Equity | -52.03M | -97.4M | 194.74M | 267.53M | 300.72M | 214.44M | 134.16M | 126.8M | 30.65M | 10.38M |
Common Stock | 1K | 1K | 7K | 8K | 8K | 8K | 8K | 9K | 11K | 11K |
Retained Earnings | -62.19M | -114.44M | -219.82M | -410.05M | -446.38M | -579.69M | -710.08M | -829.13M | -972.06M | -994.99M |
Treasury Stock | 0 | 193.44M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | -980K | -42K | 142K | 614K | -943K | -4.58M | 184K | 261K | 166K | -104K |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
ALEC Cash Flow Statement
Alector, Inc. (ALEC) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | -17.77M | 127.46M | -99.31M | -166.73M | 298.55M | -20.33M | -184.16M | -229.91M | -184.03M | -173.06M |
Operating CF Margin % | -475.8% | 460.54% | -468.01% | -790.28% | 144.17% | -15.21% | -189.74% | -228.63% | -874.46% | - |
Operating CF Growth % | -36.77% | 817.26% | -177.91% | -67.9% | 279.06% | -106.81% | -805.91% | -24.84% | 19.95% | 100.1% |
Net Income | -32.48M | -52.25M | -105.39M | -190.23M | -36.33M | -133.31M | -130.39M | -119.05M | -142.93M | -125.39M |
Depreciation & Amortization | 680K | 1.02M | 5.57M | 7.26M | 8.31M | 8.47M | 8.85M | 8.84M | -861K | 8.78M |
Stock-Based Compensation | 5.35M | 6.92M | 16.28M | 30.52M | 40.78M | 46.15M | 42.8M | 39.46M | 26.66M | 21.21M |
Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Cash Items | 6.78M | -2.59M | -3.5M | 929K | 2.1M | -1.16M | -15.27M | -12.17M | 7.16M | -879K |
Working Capital Changes | 8.68M | 174.36M | -12.27M | -15.22M | 283.68M | 59.53M | -90.15M | -146.99M | -74.06M | -76.79M |
Change in Receivables | -20K | 238K | 0 | 0 | -7.39M | 4.8M | 2.59M | 0 | 0 | 0 |
Change in Inventory | 6.58M | 2.45M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change in Payables | -41K | -809K | 152K | 2.41M | 1.92M | -572K | -377K | -1.44M | -524K | -903K |
Cash from Investing | -801K | -224.12M | -48.87M | -105.05M | -49.66M | -159.01M | 101.92M | 107.13M | 196.6M | 191.81M |
Capital Expenditures | -801K | -1.88M | -15.27M | -5.03M | -3.25M | -4.12M | -2.38M | -1.25M | -41K | -139K |
CapEx % of Revenue | 21.45% | 6.81% | 71.94% | 23.85% | 1.57% | 3.08% | 2.45% | 1.25% | 0.19% | 0.75% |
Acquisitions | 0 | 0 | 0 | 100.02M | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 0 | -222.24M | 0 | -100.02M | 0 | 0 | 0 | 0 | 0 | 0 |
Cash from Financing | -15K | 131.15M | 172.35M | 232.11M | 30.3M | 4.51M | 2.55M | 81.54M | 20.21M | 20.24M |
Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.39M | 0 | 0 |
Equity Issued (Net) | 0 | 0 | 172.35M | 224.6M | 0 | 4.51M | 2.55M | 71.11M | 20M | 20.02M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | -15K | -1.9M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing | -15K | 131.15M | 0 | 7.51M | 30.3M | 0 | 0 | 1.04M | 217K | 217K |
Net Change in Cash | -18.59M▲ 0% | 34.49M▲ 285.6% | 24.17M▼ 29.9% | -39.67M▼ 264.1% | 279.18M▲ 803.7% | -174.83M▼ 162.6% | -79.69M▲ 54.4% | -41.23M▲ 48.3% | 32.78M▲ 179.5% | 38.99M▲ 0% |
Free Cash Flow | -18.57M▲ 0% | 125.58M▲ 776.2% | -114.57M▼ 191.2% | -171.77M▼ 49.9% | 295.3M▲ 271.9% | -24.45M▼ 108.3% | -186.54M▼ 663.1% | -231.16M▼ 23.9% | -184.07M▲ 20.4% | -173.2M▲ 0% |
FCF Margin % | -497.24% | 453.73% | -539.95% | -814.13% | 142.6% | -18.3% | -192.19% | -229.88% | -874.66% | -940.44% |
FCF Growth % | -21.84% | 776.18% | -191.24% | -49.92% | 271.92% | -108.28% | -663.08% | -23.92% | 20.37% | 24.72% |
FCF per Share | -0.36 | 1.84 | -1.86 | -2.21 | 3.67 | -0.30 | -2.23 | -2.39 | -1.79 | -1.57 |
FCF Conversion (FCF/Net Income) | 0.55x | -2.44x | 0.94x | 0.88x | -8.22x | 0.15x | 1.41x | 1.93x | 1.29x | 1.38x |
Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4K |
Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
ALEC Key Ratios
Alector, Inc. (ALEC) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | - | - | -216.52% | -82.3% | -12.79% | -51.75% | -74.81% | -91.24% | -181.56% | -295.17% |
Return on Invested Capital (ROIC) | - | - | - | -69.38% | -19.46% | -168.61% | -112.7% | -92.62% | -159.2% | -758.24% |
Gross Margin | -700.83% | -163.87% | -373.76% | -643.53% | 8.54% | 100% | 90.88% | 100% | 54.09% | 88.68% |
Net Margin | -869.61% | -188.78% | -496.65% | -901.64% | -17.54% | -99.77% | -134.34% | -118.39% | -679.16% | -680.83% |
Debt / Equity | - | - | 0.25x | 0.19x | 0.16x | 0.20x | 0.29x | 0.34x | 1.18x | 3.33x |
FCF Conversion | 0.55x | -2.44x | 0.94x | 0.88x | -8.22x | 0.15x | 1.41x | 1.93x | 1.29x | 1.38x |
Revenue Growth | 797.84% | 641.02% | -23.33% | -0.57% | 881.54% | -35.48% | -27.36% | 3.6% | -79.07% | -79.15% |
Related:ALEC Dividend History·ALEC Revenue History·ALEC Price History·ALEC P/E History·ALEC Financial Ratios·ALEC Institutional Holders
ALEC SEC Filings & Documents
Alector, Inc. (ALEC) SEC filings — annual & quarterly reports (10-K, 10-Q)
ALEC Frequently Asked Questions
Alector, Inc. (ALEC) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Alector, Inc. (ALEC) reported $18.4M in revenue for fiscal year 2025. This represents a 4327% increase from $0.4M in 2016.
Alector, Inc. (ALEC) saw revenue decline by 79.1% over the past year.
Alector, Inc. (ALEC) reported a net loss of $125.4M for fiscal year 2025.
Dividend & Returns
Alector, Inc. (ALEC) has a return on equity (ROE) of -181.6%. Negative ROE indicates the company is unprofitable.
Alector, Inc. (ALEC) had negative free cash flow of $173.2M in fiscal year 2025, likely due to heavy capital investments.